Literature DB >> 28426441

Diagnosis of corneal limbal stem cell deficiency.

Kyeong Hwan Kim1, Shahzad I Mian.   

Abstract

PURPOSE OF REVIEW: A state of limbal stem cell deficiency (LSCD) can be secondary to a number of etiologies, resulting in either a reduction in the total number of limbal stem cells or an abnormality in stem cell function. Initially, the epithelium becomes irregular and hazy; however, this condition may progress to persistent corneal epithelial defects, stromal scarring, ulceration, and even perforation. Since LSCD secondary to a variety of etiologies may be reversible, and various factors are prognostic of disease progression, timely diagnosis is important. This review will describe current knowledge of diagnostic techniques for LSCD and understanding of epithelial stem cell function. RECENT
FINDINGS: Conjunctivalization, regarded as the most reliable clinical finding diagnostically, can be identified as late staining of epithelium with fluorescein. While identifying loss of the palisades of Vogt by slit-lamp examination, can provide a high suspicion of LSCD, but this is not diagnostic. Impression cytology is a simple, noninvasive technique that aids in the diagnosis of LSCD, but a negative result also cannot rule out the diagnosis. Recent findings have also shown that imaging techniques including in-vivo confocal microscope and optical coherent tomography can also aid in diagnosing LSCD; however, several challenges remain before these techniques become standard diagnostic methods in clinical practice. Meanwhile, determination of the absence of limbal epithelial crypts and focal stromal projections using image reconstruction techniques may assist in the diagnosis of LSCD. Furthermore, histologic markers may help not only to improve sensitivity and specificity of conventional techniques in diagnosis of LSCD, but also to identify human limbal stem cells and determine their number and function in LSCD.
SUMMARY: Efforts to develop and improve techniques for diagnosing LSCD are ongoing. Increased knowledge of limbal stem cells and components of their niches may not only help in understanding the pathogenesis of LSCD but may improve its diagnosis, thereby ameliorating the prognosis of patients with this devastating disease.

Entities:  

Mesh:

Year:  2017        PMID: 28426441     DOI: 10.1097/ICU.0000000000000387

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  6 in total

Review 1.  Niche regulation of limbal epithelial stem cells: HC-HA/PTX3 as surrogate matrix niche.

Authors:  Scheffer C G Tseng; Szu-Yu Chen; Olivia G Mead; Sean Tighe
Journal:  Exp Eye Res       Date:  2020-08-12       Impact factor: 3.467

Review 2.  Emerging Therapeutic Strategies for Limbal Stem Cell Deficiency.

Authors:  Ying Dong; Han Peng; Robert M Lavker
Journal:  J Ophthalmol       Date:  2018-06-27       Impact factor: 1.909

Review 3.  Limbal niche cells are a potent resource of adult mesenchymal progenitors.

Authors:  Ping Guo; Hong Sun; Yuan Zhang; Sean Tighe; Shuangling Chen; Chen-Wei Su; Yongsong Liu; Hongxia Zhao; Min Hu; Yingting Zhu
Journal:  J Cell Mol Med       Date:  2018-04-20       Impact factor: 5.310

4.  Evaluation of limbal transplantation in eyes with bilateral severe ocular surface damage secondary to chemical injury.

Authors:  Abdel Hamid El-Hofi; Hany Ahmed Helaly
Journal:  Clin Ophthalmol       Date:  2019-02-18

5.  Time-course single-cell RNA sequencing reveals transcriptional dynamics and heterogeneity of limbal stem cells derived from human pluripotent stem cells.

Authors:  Changbin Sun; Hailun Wang; Qiwang Ma; Chao Chen; Jianhui Yue; Bo Li; Xi Zhang
Journal:  Cell Biosci       Date:  2021-01-23       Impact factor: 7.133

6.  Evaluation of an Improved Chitosan Scaffold Cross-Linked With Polyvinyl Alcohol and Amine Coupling Through 1-Ethyl-3-(3-Dimethyl Aminopropyl)-Carbodiimide (EDC) and 2 N-Hydroxysuccinimide (NHS) for Corneal Applications.

Authors:  Mohamed Ali Seyed; Kavitha Vijayaraghavan
Journal:  Open Access Maced J Med Sci       Date:  2018-09-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.